炎症性肠病组织学活动与严重感染风险:一项全国性研究
这项基于瑞典全国人群的研究纳入1990至2016年诊断的55626例炎症性肠病患者,随访至2016年。组织学炎症(对比组织学缓解)与严重感染风险升高相关(校正HR 1.59,95%CI 1.48-1.72),在溃疡性结肠炎和克罗恩病中均一致,败血症和机会性感染风险亦升高。
要点
- 组织学炎症者严重感染发生率为4.62/100人年,组织学缓解者为2.53/100人年。
- 组织学炎症对比缓解的严重感染校正HR为1.59(95%CI 1.48-1.72)。
- 败血症和机会性感染的校正HR分别为1.66和1.71。
核心结论
- 炎症性肠病的组织学炎症是严重感染(包括败血症)的独立危险因素,提示实现组织学缓解可能减少感染。
研究设计与样本
- 全国性人群研究,纳入1990至2016年诊断的55626例炎症性肠病患者,随访至2016年,使用Cox回归估计风险比。
主要发现
- 组织学炎症对比缓解的严重感染发生率为4.62 vs 2.53/100人年,校正HR 1.59(95%CI 1.48-1.72)。
- 溃疡性结肠炎中组织学炎症对比缓解的校正HR为1.68(95%CI 1.51-1.87),克罗恩病为1.59(95%CI 1.40-1.80)。
- 败血症校正HR 1.66(95%CI 1.28-2.15),机会性感染校正HR 1.71(95%CI 1.22-2.41)。
- 按年龄、性别和教育水平分层结果一致,进一步校正炎症性肠病相关药物后校正HR为1.47(95%CI 1.34-1.61)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Individuals with inflammatory bowel disease (IBD) are at increased risk of serious infections, but whether this risk varies by histologic disease activity is unclear. METHODS: This was a national population-based study of 55,626 individuals diagnosed with IBD in 1990 to 2016 with longitudinal data on ileocolorectal biopsy specimens followed up through 2016. Serious infections were defined as having an inpatient infectious disease diagnosis in the Swedish National Patient Register. We used Cox regression to estimate hazard ratios (HRs) for serious infections in the 12 months after documentation of histologic inflammation (vs histologic remission), adjusting for social and demographic factors, chronic comorbidities, prior IBD-related surgery, and hospitalization. We also adjusted for IBD-related medications in sensitivity analyses. RESULTS: With histologic inflammation vs remission, there was 4.62 (95% CI, 4.46-4.78) and 2.53 (95% CI, 2.36-2.70) serious infections per 100 person-years of follow-up, respectively (adjusted HR [aHR], 1.59; 95% CI, 1.48-1.72). Histologic inflammation (vs remission) was associated with an increased risk of serious infections in ulcerative colitis (aHR, 1.68; 95% CI, 1.51-1.87) and Crohn's disease (aHR, 1.59; 95% CI, 1.40-1.80). The aHRs of sepsis and opportunistic infections were 1.66 (95% CI, 1.28-2.15) and 1.71 (95% CI, 1.22-2.41), respectively. Overall, results were consistent across age groups, sex, and education level, and remained largely unchanged after adjustment for IBD-related medications (aHR, 1.47; 95% CI, 1.34-1.61). CONCLUSIONS: Histologic inflammation of IBD was an independent risk factor of serious infections, including sepsis, suggesting that achieving histologic remission may reduce infections in IBD. The study was approved by the Stockholm Ethics Review Board (approval numbers 2014/1287-31/4, 2018/972-32, and 2021-06209-01).
引用
- Mårild K, Söderling J, Axelrad J, et al. Histologic Activity in Inflammatory Bowel Disease and Risk of Serious Infections: A Nationwide Study. Clin Gastroenterol Hepatol. 2023. PMID: 37913937. doi:10.1016/j.cgh.2023.10.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。